Quantcast
Last updated on April 17, 2014 at 21:23 EDT

Latest Rare diseases Stories

2014-03-31 08:29:52

Defitelio®? (defibrotide) Launch Announced During the 40th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) 2014 DUBLIN and VILLA GUARDIA, Italy, March 31, 2014 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and Gentium S.p.A., a Jazz Pharmaceuticals company, today announced the commencement of the European commercial launch of Defitelio®(?) (defibrotide), the first licensed product for the treatment of severe hepatic veno-occlusive...

2014-03-28 11:31:26

Researchers at the UC San Diego School of Medicine have demonstrated for the first time that veterans of the 1990-91 Persian Gulf War who suffer from "Gulf War illness" have impaired function of mitochondria – the energy powerhouses of cells. The findings, published in the March 27, 2014 issue of PLOS ONE, could help lead to new treatments benefitting affected individuals – and to new ways of protecting servicepersons (and civilians) from similar problems in the future, said principal...

2014-03-26 16:25:21

NASHVILLE, Tenn., March 26, 2014 /PRNewswire-USNewswire/ -- Two pediatricians whose research led to the need for early identification of and treatment of severe combined immunodeficiency (SCID) and its inclusion in newborn screening have received the March of Dimes/Col. Harland D. Sanders Lifetime Achievement Award in Genetics. Children affected with SCID are at risk of developing life-threatening infections because they lack a normal immune system. The disorder became familiar to...

2014-03-26 16:18:12

In mice, dietary changes slow down progression of the disease Working with genetically engineered mice, Johns Hopkins neuroscientists report they have identified what they believe is the cause of the vast disintegration of a part of the brain called the corpus striatum in rodents and people with Huntington's disease: loss of the ability to make the amino acid cysteine. They also found that disease progression slowed in mice that were fed a diet rich in cysteine, which is found in foods...

2014-03-25 23:32:53

Natural Urticaria And Angioedema Treatment created by Dr.Gary M Levin is the latest program that teaches people how to stop their urticaria and angioedema. An overview on the website Vinaf.com shows if the program is good for people to use. New York, NY (PRWEB) March 25, 2014 Natural Urticaria And Angioedema Treatment was created by Dr. Gary M Levin, who has many years of experience in studying hives treatments. The program provides people with a lot of natural remedies, techniques, and...

2014-03-24 20:23:30

In the news release, Antioxidant Shows Promise in Supporting Treatment for Lou Gehrig's Disease, issued 24-Mar-2014 over PR Newswire, we are advised by the company that the source being attributed should be "The Center of Free Radical and Biomedical Research" rather than "MitoQ Limited"; and the headline should read "Antioxidant Shows Promise in Fight Against Lou Gehrig's Disease" rather than "Antioxidant Shows Promise in Supporting Treatment for Lou Gehrig's Disease" as originally issued...

2014-03-24 08:27:10

MONTEVIDEO, Uruguay, March 24, 2014 /PRNewswire/ -- Researchers at The Center of Free Radical and Biomedical Research at Facultad de Medicina, Universidad de la Republica in Uruguay today announced the discovery that the antioxidant MitoQ prolonged the lifespan and health-span of mice suffering from amyotrophic lateral sclerosis-like (ALS) disease, and successfully improved functional parameters related to muscular strength and reversed mitochondrial damage in nervous and muscle...

2014-03-21 23:26:31

The conference offers physicians, nurses, and specialists an opportunity to understand more about identifying mitochondrial diseases, managing adults and children with mitochondrial disorders, and assisting patients with treatment options and coordinated care. Boston, MA (PRWEB) March 21, 2014 In an ongoing effort to improve mitochondrial disease patient care, MitoAction will host the 2014 Mitochondrial Disease Clinical Conference Boston on May 3, 2014 at Mandarin Oriental. This is...

2014-03-21 23:25:53

As part of its $219,000 initial multiple system atrophy research grant funding round, The MSA Coalition® has awarded $25,00 to Dr. Roy Freeman of Beth Israel Deaconess Medical Center for research to determine whether alpha-synuclein deposits are a valid biomarker for multiple system atrophy. Boston, MA (PRWEB) March 21, 2014 The Multiple System Atrophy Coalition has awarded a $25,000 grant to Dr. Roy Freeman of Beth Israel Deaconess Medical Center to carry out a pilot study to...

2014-03-19 23:32:15

Eduardo Benarroch, M.D. of the Mayo Clinic in Rochester, MN. Has been awarded a research grant for his project "Mechanisms of Excessive Daytime Sleepiness and Sleep Related Respiratory Dysfunction in MSA.” In January 2014, The MSA Coalition announced the funding of five MSA research grants for a total of $219,000. Richester, MN (PRWEB) March 19, 2014 The Multiple System Atrophy Coalition has awarded a $50,000 grant to Dr. Eduardo Benarroch of the Mayo Clinic Rochester for a new...